1. P884: POTENTIAL BENEFIT OF POST-TRANSPLANT DOXYCYCLINE IN AL ACHIEVING HEMATOLOGICAL RESPONSE AFTER AUTOLOGOUS STEM CELL TRANSPLANT – LONG TERM FOLLOW UP. (23rd June 2022) Authors: Abdallah, N.; Dispenzieri, A.; Muchtar, E.; Buadi, F.; Kapoor, P.; Lacy, M.; Hwa, Y.; Fonder, A.; Hobbs, M.; Hayman, S.; Leung, N.; Dingli, D.; Go, R.; Lin, Y.; Gonsalves, W.; Binder, M.; Kourelis, T.; Warsame, R.; Kyle, R.; Rajkumar, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE. (23rd June 2022) Authors: Vaxman, I.; Kumar, S.; buadi, F.; Lacy, M.; Dingli, D.; Fonder, A.; Hobbs, M.; Hayman, S.; hwa, L. Y.; Kouralis, T.; Warsame, R.; Muchtar, E.; Nelson, L.; Kapoor, P.; Grogan, M.; Go, R.; Gonsalves, W.; Siddiqi, M.; Robert, K.; Rajkumar, V. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗